Traduction de «relation to sensitive » (Néerlandais → Français) :

TERMINOLOGIE

ADTKD-UMOD - UMOD-related autosomal dominant tubulointerstitial kidney disease
néphropathie tubulo-interstitielle autosomique dominante associée à UMOD

ADTKD-MUC1 - MUC1-related autosomal dominant tubulointerstitial kidney disease
néphropathie tubulo-intersitielle autosomique dominante associée à MUC1

acquired immunodeficiency syndrome [AIDS] NNO | AIDS-related complex [ARC] NNO
Complexe relatif au SIDA [ARC] SAI Syndrome d'immunodéficience acquise [SIDA] SAI

TRADUCTIONS EN CONTEXTE

Ook in Europese context wordt de toestemming van de patiënt als “good medical practice” bestempeld, zoals blijkt: “Although consent can be presumed for the recording and sharing of information required for healthcare within the immediate healthcare team, it is good practice to obtain specific consent for this process, particularly in relation to sensitive information.
Le consentement du patient est également considéré dans le contexte européen comme une « good medical practice », ainsi : « Bien que le consentement soit présumé pour l’enregistrement et le partage d’informations requises pour la prestation des soins de santé au sein de l’équipe directe de soins, il est judicieux, dans la pratique, d’obtenir un accord spécifique pour ceci, particulièrement pour ce qui concerne des informations sensibles.

EFSA - European Food Safety Authority. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of health claims related to conjugated linoleic acid (CLA) isomers and contribution to the maintenance or achievement of a normal body weight (ID 686, 726, 1516, 1518, 2892, 3165), increase in lean body mass (ID 498, 731), increase in insulin sensitivity (ID 1517), protection of DNA, proteins and lipids from oxidative damage (ID 564, 1937), and contribution to immune defences by stimulation of production of protective antibodies in response to vaccination (ID 687, 1519) pursuant to Article 13(1) of Regulation (EC) No 1924/2006.
linoleic acid (CLA) isomers and contribution to the maintenance or achievement of a normal body weight (ID 686, 726, 1516, 1518, 2892, 3165), increase in lean body mass (ID 498, 731), increase in insulin sensitivity (ID 1517), protection of DNA, proteins and lipids from oxidative damage (ID 564, 1937), and contribution to immune defences by stimulation of production of protective antibodies in response to vaccination (ID 687, 1519) pursuant to Article 13(1) of Regulation (EC) No 1924/2006.